Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Clears Wyeth’s Pristiq For Depression

Feb 29 2008

• By Randall Osborne

Related Content

Wyeth Ends Bifeprunox For Schizophrenia Development Deal With Solvay

Feb 29 2008

Pristiq Low Dose Shows Benefit In Treating MDD

Dec 12 2007

FDA Asks Wyeth For Additional Safety Study To Support Pristiq Vasomotor Claim

Jul 24 2007

Wyeth’s Pristiq Deemed “Approvable” By FDA

Jan 23 2007

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window